Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine

@article{Bulotta2015EmergingSF,
  title={Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine},
  author={Stefania Bulotta and Marilena Celano and Giuseppe Costante and Diego Russo},
  journal={Endocrine},
  year={2015},
  volume={52},
  pages={214-221}
}
Abstract Efficient treatment of radio refractory thyroid cancer is still a major challenge. The recent identification of genetic and epigenetic alterations present in almost all differentiated tumors has revealed novel molecular targets, which can hopefully be exploited to create new treatments for these tumors. This review looks briefly at some of the innovative strategies currently being investigated for the treatment the radioiodine-resistant thyroid cancers. 

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Effects of nutraceuticals on anaplastic thyroid cancer cells

  • Journal of Cancer Research and Clinical Oncology
  • 2017
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Lack of association between obesity and aggressiveness of differentiated thyroid cancer

  • Journal of Endocrinological Investigation
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

MicroRNAs as Biomarkers in Thyroid Carcinoma

  • International journal of genomics
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 78 REFERENCES

Molecular pathogenesis and mechanisms of thyroid cancer

  • Nature Reviews Cancer
  • 2013
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Phay, A novel dual AMPK activator/ mTOR inhibitor inhibits thyroid cancer cell growth

R. L. Plews, A. Mohd Yusof, +4 authors J.E.M.D. Ringel
  • J. Clin. Endocrinol. Metab 100,
  • 2015